Validity of the Oxford classification of IgA nephropathy in children
Abstract Background In 2009, the Oxford classification of IgA nephropathy was published.
However, its validity has not been fully examined in children. This study aimed to assess this …
However, its validity has not been fully examined in children. This study aimed to assess this …
[HTML][HTML] Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
Abstract Background The Oxford classification of IgA nephropathy (IgAN) provides a useful
tool for prediction of renal prognosis. However, the application of this classification in …
tool for prediction of renal prognosis. However, the application of this classification in …
Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)
S Edström Halling, MP Söderberg… - Nephrology Dialysis …, 2012 - academic.oup.com
Background. There has been a lack of international consensus on the classification and the
predictive value of the histopathology findings in IgA nephropathy (IgAN). Recently, the …
predictive value of the histopathology findings in IgA nephropathy (IgAN). Recently, the …
Henoch-Schönlein purpura nephritis: an update
JC Davin, J Weening - European journal of pediatrics, 2001 - Springer
Henoch-Schönlein purpura (HSP) is a form of systemic vasculitis characterised by vascular
wall deposits of predominally IgA typically involving small vessels in skin, gut and glomeruli …
wall deposits of predominally IgA typically involving small vessels in skin, gut and glomeruli …
[HTML][HTML] Biomarkers of IgA vasculitis nephritis in children
E Pillebout, A Jamin, H Ayari, P Housset, M Pierre… - PloS one, 2017 - journals.plos.org
Henoch–Schönlein purpura is a systemic vasculitis characterized by IgA deposits, which
target the skin, joints, and kidneys, among other organs. In children, prognosis is often good …
target the skin, joints, and kidneys, among other organs. In children, prognosis is often good …
Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome
S Ohara, Y Kawasaki, H Matsuura, T Oikawa… - Clinical and …, 2011 - Springer
Henoch–Schönlein purpura (HSP) is a systemic disorder characterized by leukocytoclastic
vasculitis involving the capillaries and the deposition of IgA immune complexes. Renal …
vasculitis involving the capillaries and the deposition of IgA immune complexes. Renal …
[HTML][HTML] Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children
S Mao, X Xuan, Y Sha, S Zhao, C Zhu… - … journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Objective: Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) are
similar syndromes. We aimed to determine whether the crescent formation/immunocomplex …
similar syndromes. We aimed to determine whether the crescent formation/immunocomplex …
[HTML][HTML] Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial
Y Ding, X Zhang, X Ren, W Zhai, L He, J Liu, C Yao… - Trials, 2019 - Springer
Abstract Background Henoch-Schönlein purpura nephritis (HSPN) is the most common
secondary glomerular disease in children. Currently, the treatment for HSPN is always …
secondary glomerular disease in children. Currently, the treatment for HSPN is always …
[HTML][HTML] A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy
M Sugiyama, Y Wada, N Kanazawa, S Tachibana… - PLoS …, 2020 - journals.plos.org
Introduction Recent studies noted that Henoch-Schönlein purpura nephritis (HSPN) and IgA
nephropathy (IgAN) share the feature of galactose-deficient IgA1 (Gd-IgA1)-oriented …
nephropathy (IgAN) share the feature of galactose-deficient IgA1 (Gd-IgA1)-oriented …
Methylprednisolone or cyclosporine a in the treatment of Henoch-Schönlein nephritis: a nationwide study
M Koskela, T Jahnukainen, K Endén, P Arikoski… - Pediatric …, 2019 - Springer
Abstract Background Optimal treatment of Henoch-Schönlein purpura nephritis (HSN)
remains unclear. We evaluated outcome of pediatric HSN patients treated initially with either …
remains unclear. We evaluated outcome of pediatric HSN patients treated initially with either …